FIBROGEN INC (FGEN) has 341 open-market insider trades by 21 insiders since 2015. The most active filer is Thomas B. Neff, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Thomas B. Neff | CEO | — | 120 | $132.4M | 2019-08-22 |
| Thomas B. Neff | CEO | — | 17 | $32.5M | 2019-08-22 |
| Pat Cotroneo | CFOVP | — | 38 | $26.0M | 2021-09-07 |
| K. Peony Yu | — | — | 30 | $12.4M | 2020-12-16 |
| Rory B. Riggs | Dir | — | 5 | $9.2M | 2021-05-26 |
| Kalevi Kurkijarvi | Dir | — | 38 | $7.8M | 2021-05-26 |
| Christine Chung | VP | — | 22 | $7.1M | 2025-03-06 |
| Thomas F. Kearns Jr. | Dir | — | 7 | $4.3M | 2021-09-15 |
| Toshinari Tamura | Dir | — | 3 | $4.2M | 2019-06-05 |
| Enrique A. Conterno | CEO | — | 8 | $3.8M | 2023-07-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Thane Wettig | CEO | Buy | $34K | 2025-11-13 |
| James A. Schoeneck | Director | Buy | $239K | 2025-06-30 |
| Thane Wettig | CEO | Buy | $51K | 2025-03-24 |
| James A. Schoeneck | Director | Buy | $105K | 2025-03-20 |
| Deyaa Adib | Chief Medical Officer | Buy | $26K | 2024-06-12 |
| Thane Wettig | CEO | Buy | $96K | 2024-03-07 |
Companies that share insiders with FGEN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey William Henderson | Director | Sell | $2K | 2023-09-01 |
| Jeffrey William Henderson | Director | Sell | $4K | 2023-08-04 |
| Jeffrey William Henderson | Director | Sell | $5K | 2023-07-11 |
| Enrique A. Conterno | CEO | Sell | $5K | 2023-07-07 |
| Thane Wettig | Chief Commercial Officer | Sell | $13K | 2023-06-23 |
| Christine Chung | VP | Sell | $325K | 2023-06-13 |
| Jeffrey L. Edwards | Director | Sell | $271K | 2023-06-09 |
| Suzanne Blaug | Director | Sell | $293K | 2023-06-09 |
| Aoife Brennan | Director | Sell | $81K | 2023-06-09 |